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Summary  Myocardial  late  enhancement,  an  imaging  technique  acquired  after  gadolinium
administration,  has  become  an  integral  part  of  cardiovascular  magnetic  resonance  imaging  over
the past  decade.  Initially  principally  utilized  for  imaging  myocardial  infarction,  more  recently  it
has also  become  an  invaluable  tool  for  identifying  myocardial  scarring  in  other  cardiomyopathic
processes.  Our  experience  using  this  technique  has  led  us  to  identify  several  manifestations
of late  gadolinium  enhancement  imaging  that  can  confound  interpretation  of  pathology  and
potentially  lead  to  misinterpretation  and  subsequently  misdiagnosis  for  the  patient.  The  purpose
of this  article  is  to  review  and  illustrate  typical  and  atypical  myocardial  late  enhancement  in
the most  common  myocardial  diseases  seen  in  routine  clinical  practice.
© 2012  Published  by  Elsevier  Masson  SAS.MOTS  CLÉS Résumé  Les  séquences  de  rehaussement  tardifs,  acquis  après  injection  de  produit  de
Imagerie  cardiaque
par  résonance
magnétique  ;
Rehaussement  tardif
contraste  sont  devenues  une  part  clé  de  l’IRM  cardiaque.  Initialement  utilisée  dans  l’imagerie
de l’infarctus  du  myocarde,  ces  séquences  sont  devenues  un  outil  indispensable  d’identiﬁcation
de cicatrice  myocardique  dans  un  grand  nombre  de  cardiomyopathies.  Notre  expérience  dans
ce domaine  nous  a  conduit  à  identiﬁer  des  rehaussements  tardifs  typiques  mais  également
Abbreviations: CMR, cardiovascular magnetic resonance; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy;
GE, late gadolinium enhancement; MI, myocardial infarction; MVO, microvascular obstruction.
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atypiques  pouvant  potentiellement  conduire  à  des  diagnostics  erronés.  Le  but  de  cette  revue  est
d’identiﬁer  et  d’illustrer  des  rehaussements  tardifs  typique  et  atypiques  dans  quatre  principales
cardiomypathies  (infarctus  aigu  du  myocarde,  myocardite,  cardiopathie  dilatée  et  cardiopathie
hypertrophique).
© 2012  Publié  par  Elsevier  Masson  SAS.
Figure 1. Typical transmural infarct with microvascular obstruc-
tion: a 37-year-old male with an acute reperfused inferolateral
myocardial infarction. Mid short-axis image shows a dark zone
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enhancement
A  myocardial  LGE  study  is  performed  10  to  20  minutes  after
injection  of  an  extracellular  contrast  agent  that  distributes
in  extracellular  water  but  cannot  cross  the  intact  myocyte
cell  membrane.  LGE  imaging  utilizes  inversion-recovery  gra-
dient  echo  sequences  with  the  inversion  time  set  to  null
viable  myocardium.
The  technique  for  LGE  imaging  has  been  shown  to
be  effective  in  identifying  the  presence  and  extent  of
myocardial  scarring.  Compared  with  normal  myocardium,
the  wash  out  of  gadolinium  in  a  myocardial  scar  is  delayed.
In  the  acute  stage  (i.e.  necrosis),  leaky  cell  membranes
allow  gadolinium  to  enter  the  cells,  thereby  increas-
ing  the  volume  of  distribution  of  gadolinium,  resulting
in  a  bright  signal  intensity  of  suitable  inversion-recovery
(‘LGE’)  images  [1].  In  the  chronic  setting,  ﬁbrous  tissue
replaces  necrotic  tissue  and  is  associated  with  a  signiﬁ-
cant  expansion  of  the  interstitial  space  and  a  subsequent
increase  in  the  volume  of  distribution  of  gadolinium  [1].
The  enhancement  is  not  disease  speciﬁc  and  can  be
caused  by  ischaemic  necrosis,  inﬂammatory  or  infectious
pathology,  ischaemic  and  non-ischaemic  scars  and  tumorous
lesions.
Different  patterns  of  LGE  have  been  described,  prima-
rily  segmented  into  ischaemic  and  non-ischaemic  patterns.
Ischaemic  necrosis  expands  from  the  subendocardium  to
the  epicardium  with  increasing  coronary  occlusion  time  [2].
Infarct-related  areas  of  bright  signal  in  LGE  images  are  typi-
cally  subendocardial  with  an  increasing  degree  of  transmural
Figure 2. Atypical microvascular obstruction: an 83-year-old female w
descending artery occlusion. Four-chamber long-axis (A) and mid shor
microvascular obstruction overlying a near transmural anterior myocardi
v
t
t
dmbedded within a transmural region of late enhancement present-
ng microvascular obstruction in an infarct (arrows).
xtension,  depending  on  the  extent  of  the  infarct.  The  cir-
umferential  extent  is  related  to  the  size  of  the  perfusion
ed  and  the  location  of  the  coronary  artery  occlusion.  Con-ith an acute anterior myocardial infarction with mid left anterior
t-axis (B) images show a laminated subendocardial dark area of
al infarction (arrows).
ersely,  in  the  non-ischaemic  pattern,  the  subendocardium
ypically  is  spared,  with  the  high-signal  areas  localized  in
he  midwall  and  subepicardium,  appearing  patchy  or  more
iffuse.
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Figure 3. Typical late enhancement: 23-year-old male with myocarditis (viral prodrome, chest pain and elevated troponin). (A) Four-
chamber long-axis image shows patchy midwall and subepicardial late enhancement involving the lateral wall of the left ventricle (arrows).
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lB) Basal short-axis image shows marked midwall to subepicardial en
arrows).
For  a  number  of  ischaemic  and  non-ischaemic  disease
rocesses,  LGE  has  a  well-deﬁned  typical  pattern.  However,
GE  can  appear  atypical  and  can  be  challenging  for  the
eader.  The  purpose  of  this  article  is  to  review  and  describe
ypical  and  atypical  myocardial  LGE  in  common  myocardial
iseases.
linical setting of acute myocardial
nfarctionGE  imaging  facilitates  establishing  the  diagnosis  and  quan-
itative  assessment  of  MI.  Hyperintense  areas  of  LGE
ccurately  depict  the  location  and  extent  of  irreversibly
njured  myocardium.  Typically,  LGE  in  acute  MI  almost
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igure 4. Atypical late enhancement: 36-year—old male with myocard
ial involvement: subepicardial late enhancement on the right ventricu
ateral wall (arrows).ement in inferior, inferolateral and lateral walls of the left ventricle
lways  involves  the  subendocardial  layer,  with  increasing
egrees  of  transmurality  depending  on  the  total  occlusion
ime,  while  the  subendocardial  extent  of  infarct  depends
n  the  localization  of  the  occlusion  (proximal  versus  distal)
nd  the  size  of  the  perfusion  bed  dependent  on  the  occluded
oronary  artery.  An  acute  reperfused  MI  can  be  associated
ith  MVO  [3].  The  presence  and  absolute  amount  of  MVO
re  associated  with  adverse  left  ventricular  remodelling
nd  prognosis  [4].  In  LGE  and  other  postcontrast  images,
VO  typically  appears  as  a  low-signal  area  within  the  bright
nfarcted  zone,  lacking  signiﬁcant  uptake  of  gadolinium
nlike  the  enhanced  surrounding  infarct  tissue  (Fig.  1).  Aty-
ically,  MVO  may  involve  the  subendocardium  predomi-
antly,  which  can  be  challenging  for  the  clinician,  mimicking
 ‘normal  myocardium’  and  suggesting  a  non-ischaemic  pat-
itis. Mid short-axis image shows diffuse and heterogeneous myocar-
lar side, anteroseptal and anterior walls; focally transmural in the
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Figure 5. (A) Mid short-axis image shows extensive subepicar-
dial to midwall late enhancement in the inferoseptal, anteroseptal
and inferolateral walls of the left ventricle, with a thin subendocar-
dial black line that represents the spared subendocardium (arrows).
(B) Two-chamber long-axis image shows diffuse subepicardial late
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tern  or  a  left  ventricular  thrombus.  Careful  examination
of  short-axis  and  long-axis  views  enables  differentiation
between  thrombus,  normal  myocardium  and  MVO  (Fig.  2).
In  the  clinical  setting  of  acute  MI,  CMR  imaging  is  indi-
cated  for  accurate  assessment  of  right  and  left  ventricular
function,  identifying  the  presence  of  thrombus,  assessing
the  amount  of  salvaged  myocardium  and  guiding  prognosis
by  the  presence  of  MVO.
Clinical setting of acute myocarditis
Acute  myocarditis  is  an  inﬂammatory  disease  of  the
myocardium  associated  with  oedema,  cellular  inﬁltration
and  myocyte  necrosis  [5].  The  clinical  manifestations  of
myocarditis  vary  and  are  frequently  insidious  and  non-
speciﬁc.  CMR  is  the  non-invasive  diagnostic  tool  of  choice
for  assessing  myocarditis  and  is  recommended  in  symp-
tomatic  patients  with  suspected  myocarditis  [6].  Recently,
standard  diagnostic  CMR  criteria  for  myocarditis  have  been
proposed  based  on  oedema,  hyperaemia/capillary  leakage
and  irreversible  injury  (necrosis/ﬁbrosis)  detected  in  T2-
weighted  and  T1-weighted  images  before  and  after  contrast
administration  [6].  If  two  or  more  of  the  three  criteria  are
positive,  the  diagnostic  accuracy  is  78%,  while  LGE  imaging
alone  has  a  diagnostic  accuracy  of  68%  with  limited  sensiti-
vity.
In  acute  myocarditis,  areas  of  LGE  represent  irreversibly
injured  myocardial  tissue  related  to  increased  volume  of  dis-
tribution  as  a  result  of  myocardial  necrosis  [7].  Typically,  LGE
is  located  in  the  lateral,  inferolateral  or  inferior  wall  with  a
midwall  to  subepicardial  distribution;  in  young  male  patients
a  ‘pearl  necklace’  is  observed  frequently  (Fig.  3).  These
regional  distribution  patterns  are  distinct  from  the  more
uniform  patterns  found  in  MI,  which  consistently  includes
the  subendocardium.  Importantly,  however,  atypical  cases
of  myocarditis  may  present  with  transmural  (Fig.  4)  or  dif-
fuse  enhancement  (Fig.  5).
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Figure 6. Late enhancement in a 58-year-old man with severe ischae
short-axis (B) images show near transmural late enhancement in the mid
irreversible damage in the left anterior descending territory.nhancement in the anterior and inferior walls of the left ventricle
arrows).
In  the  clinical  setting  of  acute  myocarditis,  CMR  rep-
esents  the  non-invasive  tool  of  choice;  it  allows  for
he  assessment  of  the  activity  of  inﬂammatory  changes,
ncluding  myocardial  oedema,  hyperaemia  and  degree  of
rreversible  injury.  CMR  is  able  to  differentiate  acute  inﬂam-
ation  from  chronic  forms.  The  prognostic  signiﬁcance  of
MR  criteria  for  myocarditis  is  currently  not  known.linical setting of dilated cardiomyopathy
CM  is  characterized  by  enlargement  of  the  left  ventricle  or
oth  ventricles,  associated  with  globally  impaired  systolic
mic dilated cardiomyopathy. Two-chamber long-axis (A) and mid
-to-apical anterior and anteroseptal segments (arrows), indicating
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Figure 7. Diffuse late enhancement in a 46-year-old man with dilated cardiomyopathy. Mid short-axis (A) and four-chamber long-axis (B)
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tmages show diffuse midwall late enhancement (arrows) within the
unction.  DCM  may  be  caused  by  ischaemic  or  non-ischaemic
etiologies,  including  myocarditis,  inﬁltrative  disease,  cyto-
oxicity,  metabolic  disease  or  idiopathic  disease.
CMR  has  emerged  as  an  important  tool  for  the  evalua-
ion  of  DCM,  providing  accurate  information  about  cardiac
orphology,  function  and  tissue  characterization  [8,9]. LGE
mages  may  show  hyperintense  areas  that  reﬂect  ﬁbrosis,
hich  is  associated  with  impaired  prognosis  [10]. The  pat-
ern  of  LGE  can  offer  important  information  regarding  the
nderlying  aetiology  of  DCM.  In  ischaemic  DCM,  LGE  is  typi-
ally  subendocardial,  ﬁtting  a  coronary  distribution  (Fig.  6).
onversely,  in  patients  with  non-ischaemic  cardiomyopathy,
he  typical  LGE  pattern  shows  a  midmyocardial,  layered
‘midwall  sign’)  or  subepicardial  appearance,  not  matching
 coronary  perfusion  bed.
LGE  may  even  be  diffuse  within  the  myocardium  (Fig.  7)
r  localized,  predominantly  in  the  inferoseptal  wall  (Fig.  8).
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igure 8. Late enhancement mid septum in a 54-year-old woman wi
ong-axis (B) images show linear non-ischaemic midwall late enhanceme
he late enhancement is brighter than the blood pool indicating that it rventricle, consistent with non-ischaemic cardiomyopathy.
n this  latter  case,  LGE  must  be  distinguished  from  mimickers
f  late  enhancement,  such  as  a  prominent  septal  perforator
Fig.  9)  or  right  ventricular  trabeculation  (Fig.  10);  these
ay  mimic  septal  LGE  in  long-  and  short-axis  images  and
ay  lead  to  false  positive  results.
In  the  clinical  setting  of  DCM,  CMR  is  indicated  for  accu-
ate  assessment  of  ventricular  function  and  dilatation  and
or  guiding  the  aetiology  of  DCM  according  to  the  pattern  of
GE  (ischaemic  or  non-ischaemic).
linical setting of hypertrophic
ardiomyopathyCM  is  a  genetic  cardiac  disorder  characterized  by  hypertro-
hy  of  the  left  ventricle  in  the  absence  of  any  hypertrophic
timuli,  with  a  non-dilated  left  ventricle.
th dilated cardiomyopathy. Basal short-axis (A) and four-chamber
nt located in the basal mid septal wall (arrows). Signal intensity of
epresents true late enhancement.
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Figure 9. False positive late enhancement: septal perforator in a 64-year-old woman. Basal short-axis (A) and two-chamber long-axis (B)
images show linear region of increased midwall signal intensity. This has a tapered appearance with a similar signal intensity to that of the
blood pool. Overhanging muscle bundles are not identiﬁed, suggesting that this likely represents a septal perforator mimicking a midwall
late enhancement in the basal septal wall. (C) Coronary angiogram reveals a dominant septal perforator (arrows).
Figure 10. False positive late enhancement: right ventricular trabeculation in a 64-year-old man. Mid short-axis (A) and four-chamber
long-axis (B) images show a linear region of increased signal intensity in the basal septal wall (arrows). There is myocardial discontinuity
along the inferior extent of the mid septum, which conﬁrms that the ridge of myocardium infarct represents a right ventricular muscle
bundle, with contrast extending underneath the muscle rather than a true midwall focus of late enhancement.
306  E.  Vermes  et  al.
Figure 11. Typical focal late enhancement: a 52-year-old male with asymmetrical hypertrophic cardiomyopathy (basal to mid inferosep-
tal). (A) Mid short-axis image shows focal patchy late enhancement mainly conﬁned to the superior and inferior right ventricular insertion
points (arrows). Subepicardium and midwall myocardium are maximally involved at the superior insertion point. (B) Two-chamber long-axis
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mination  of  choice  for  the  detection  of  the  apical  forms  of
F
c
(mage shows subepicardial to midwall late enhancement in the bas
Transthoracic  echocardiography  is  the  ﬁrst-line  ima-
ing  modality  for  diagnosing  HCM.  However,  CMR  imag-
ng  has  evolved  into  a  highly  useful  technique,  providing
 complete  description  of  abnormalities  in  HCM,  includ-
ng  morphology,  mass,  function,  haemodynamic  obstruction
nd  tissue  characterization  [11,12].  LGE  imaging  provides
vidence  for  myocardial  ﬁbrosis  in  HCM  being  an  inde-
endent  predictor  of  cardiovascular  death  and  arrhythmia
13].
The  typical  pattern  of  LGE  includes  focal  areas  of  bright
ignal  in  hypertrophied  regions  or  small  patches  close  to
he  superior  and  inferior  right  ventricular  insertion  points
Fig.  11).  Atypically,  LGE  can  extend  into  the  right  ventri-
le  (Fig.  12)  or  can  also  involve  non-hypertrophied  segments
Fig.  13).  Myocardial  ﬁbrosis  may  be  diffuse  and  more
H
c
f
igure 12. Typical diffuse late enhancement: a 29-year-old woman wit
hamber long-axis (B) images show very extensive mid wall late enhanc
arrows).mid anterior and inferior walls (arrows).
xtensive,  making  distinction  from  inﬁltrative  cardiomy-
pathy  more  difﬁcult  (Fig.  14).  In  the  setting  of  apical
CM,  the  apical  wall  of  the  left  ventricle  may  develop
hronic  ischaemia  with  wall  thinning  in  the  absence  of
picardial  coronary  artery  disease.  In  this  setting,  LGE
an  be  transmural,  mimicking  ischaemic  injury  as  in  MI
Fig.  15).
In  the  clinical  setting  of  HCM,  CMR  is  indicated  for  accu-
ate  assessment  of  left  ventricular  mass  and  location  of  left
entricular  hypertrophy  as  well  as  for  guiding  prognosis  by
he  degree  of  myocardial  ﬁbrosis.  CMR  is  probably  the  exa-CM  and  for  evaluating  the  involvement  of  the  right  ventri-
le.  Furthermore,  CMR  can  be  used  for  guiding  biopsy  and
or  follow-up  after  septal  ablation.
h known hypertrophic cardiomyopathy. Mid short-axis (A) and four-
ement in the left ventricle extended to the entire right ventricle
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Figure 13. Typical and atypical LE in the same patient: a 20-year-
old male with apical hypertrophic cardiomyopathy. Three-chamber
long-axis image shows typical apical late enhancement but an
atypical basal midwall late enhancement in the inferolateral wall
(arrows), corresponding to a non-hypertrophied area.
Figure 15. A 54-year-old male with known apical hypertrophic
cardiomyopathy. Two-chamber long-axis image shows transmural
late enhancement at the apex of the left ventricle with a similar
appearance to that of an apical myocardial infarct but with nor-
mal epicardial coronary arteries. There is near obliteration of the
mid cavity by myocardial hypertrophy and hypertrophic papillary
muscle.
Figure 14. Atypical late enhancement: a 47-year-old female sent for myocardial biopsy for suspected inﬁltrative cardiomyopathy based
on cardiovascular magnetic resonance imaging. Biopsy conﬁrmed diagnosis of hypertrophic cardiomyopathy. Two-chamber long-axis (A) and
mid short-axis (B) images show patchy diffuse midwall late enhancement in the inferolateral, inferior and inferoseptal walls (arrows).
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